2017

Vokuhl C, Nourkami-Tutdibi N, Furtwängler R, Gessler M, Graf N, Leuschner I
ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study
Pediatr Blood Cancer. 2017 Dec 29. doi: 10.1002/pbc.26925 -> Abstract PubMed

Hontecillas-Prieto L, Garcia-Dominguez DJ, Vaca DP, Garcia-Mejias R, Marcilla D, Ramirez-Villar GL, Saez C, de Álava E
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
Oncotarget. 2017 Feb 14;8(7):11173-11186. doi: 10.18632/oncotarget.14491 -> Abstract PubMed

Wu MK, Vujanic GM, Fahiminiya S, Watanabe N, Thorner PS, O'Sullivan MJ, Fabian MR, Foulkes WD
Anaplastic sarcomas of the kidney are characterized by DICER1 mutations
Mod Pathol. 2017 Sep 1. doi: 10.1038/modpathol.2017.100 -> Abstract PubMed

Cafferata C, Cacciavillano W, Galluzzo ML, Flores P, Rose A, Zubizarreta P
Outcome of Nephroblastoma Treatment According to the SIOP-2001 Strategy at a Single Institution in Argentina
J Pediatr Hematol Oncol. 2017 Jan;39(1):50-55 -> Abstract PubMed

Charlton J, Irtan S, Bergeron C, Pritchard-Jones K
Bilateral Wilms tumour: a review of clinical and molecular features
Expert Rev Mol Med. 2017 Jul 18;19:e8. doi: 10.1017/erm.2017.8 -> Abstract PubMed

Spreafico F, Biasoni D, Lo Vullo S, Gandola L, D'Angelo P, Terenziani M, Bianchi M, Provenzi M, Indolfi P, Pession A, Nantron M, Di Cataldo A, Morosi C, Perotti D, Catania S, Bellani FF, Collini P; AIEOP Wilms Tumor Working Group
Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related Considerations
J Urol. 2017 Nov;198(5):1138-1145. doi: 10.1016/j.juro.2017.06.081 -> Abstract PubMed

D'Angelo P, Di Cataldo A, Terenziani M, Bisogno G, Collini P, Di Martino M, Melchionda F, Mosa C, Nantron M, Perotti D, Puccio G, Serra A, Catania S, Spreafico F; AIEOP Wilms Tumor Working Group
Factors possibly affecting prognosis in children with Wilms' tumor diagnosed before 24 months of age: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Wilms Tumor Working Group
Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26644 -> Abstract PubMed

van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, van Tinteren H, Furtwängler R, Verschuur AC, Vujanic GM, Leuschner I, Brok J, Rübe C, Smets AM, Janssens GO, Godzinski J, Ramírez-Villar GL, de Camargo B, Segers H, Collini P, Gessler M, Bergeron C, Spreafico F, Graf N; International Society of Paediatric Oncology - Renal Tumour Study Group (SIOP–RTSG)
Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol
Nat Rev Urol. 2017 Oct 31. doi: 10.1038/nrurol.2017.163 -> Abstract PubMed

Hol JA, van den Heuvel-Eibrink MM, Graf N, Pritchard-Jones K, Brok J, van Tinteren H, Howell L, Verschuur A, Bergeron C, Kager L, Catania S, Spreafico F, Mavinkurve-Groothuis AMC
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group
Pediatr Blood Cancer. 2017 Oct 27. doi: 10.1002/pbc.26849 -> Abstract PubMed

Wegert J, Vokuhl C, Ziegler B, Ernestus K, Leuschner I, Furtwängler R, Graf N, Gessler M
TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia
J Pathol Clin Res. 2017 Aug 14;3(4):234-248. doi: 10.1002/cjp2.77 -> Abstract PubMed

Vujanić GM, Apps JR, Moroz V, Ceroni F, Williams RD, Sebire NJ, Pritchard-Jones K.
Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.
Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26547 -> Abstract PubMed

Wu MK, Vujanic GM, Fahiminiya S, Watanabe N, Thorner PS, O'Sullivan MJ, Fabian MR, Foulkes WD.
Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.
Mod Pathol. 2017 Sep 1. doi: 10.1038/modpathol.2017.100 -> Abstract PubMed

Vujanic GM, Alaggio R; Paediatric Pathology Society.
In Memoriam.
Pediatr Dev Pathol. 2017 Mar-Apr;20(2):103-104. doi: 10.1177/1093526617700554 -> Abstract PubMed

Furtwängler R, Kager L, Melchior P, Rübe C, Ebinger M, Nourkami-Tutdibi N, Niggli F, Warmann S, Hubertus J, Amman G, Leuschner I, Vokuhl C, Graf N, Frühwald MC
High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience
Pediatr Blood Cancer. 2017 Aug 26. doi: 10.1002/pbc.26746 -> Abstract PubMed

Spreafico F, van den Heuvel-Eibrink MM, Pritchard-Jones K, Bergeron C, Godzinski J, Smets A, Olsen O, Vujanic G, Rübe C, van Tinteren H, Gessler M, Graf N, SIOP Renal Tumour Study Group
Paediatric renal tumours: perspectives from the SIOP-RTSG
Nat Rev Urol. 2017 Jan;14(1):3-4. doi: 10.1038/nrurol.2016.247 -> Abstract PubMed

Brok J, Pritchard-Jones K, Geller JI, Spreafico F
Review of phase I and II trials for Wilms' tumour - Can we optimise the search for novel agents?
Eur J Cancer. 2017 May 15;79:205-213. doi: 10.1016/j.ejca.2017.04.005 -> Abstract PubMed